# Pre-Exposure Prophylaxis in YMSM

> **NCT01033942** · PHASE2 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 68 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** coformulated emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF) as PrEP
- **DRUG:** Placebo
- **BEHAVIORAL:** Many Men, Many Voices (3MV)

## Key facts

- **NCT ID:** NCT01033942
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2017-04-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01033942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01033942, "Pre-Exposure Prophylaxis in YMSM". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT01033942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*